Novel <i>In Vitro</i> Cancer Models for Optimizing Anti-EGFR Therapies.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29222163.
- Also identified by DOI 10.1158/1078-0432.CCR-17-2937.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Preclinical models, which are able to recapitulate the biology and pathology of the original individual cancer, are needed to better investigate mechanisms of response and resistance to anticancer therapies. In this respect, novel <i>in vitro</i> models for metastatic colorectal cancer could be of high value. <i>Clin Cancer Res; 24(4); 727-9. ©2017 AACR</i><i>See related article by Luraghi et al., p. 807</i>.
Medical subject headings
- Colonic Neoplasms
- ErbB Receptors